This study shows that leptin induced a rapid phosphorylation of p42/44 mitogenactivated protein kinase, an enhancement of both NF-κB DNA binding and transcriptional activities, and a concentration-dependent increase of HT29 cell proliferation. These effects are consistent with the presence of leptin receptors on cell membranes. The leptin induction of cell growth was associated with an increase of cell population in S and G 2 /M phase compared to control cells found in G 0 /G 1 phase of the cell cycle. Moreover, cyclin D1 immunoreactivity was enhanced in leptin-treated HT29 cells and this increase was essentially associated with cell population in G 0 /G 1 phase. On the other hand, we observed that sodium butyrate inhibited cell proliferation by blocking the HT29 cells in G 0 /G 1 phase of the cell cycle. Interestingly, at physiological concentration, leptin prevented sodium butyrateinduced morphological nucleus changes, DNA laddering and suppressed butyrate-induced cell cycle arrest. This anti-apoptotic effect of leptin was associated with HT-29 cell proliferation and activation NF-κB pathways. However, the phosphorylation of p42/44
Introduction
Leptin, the protein product encoded by ob gene, is a 16-kDa circulating hormone produced primarily by the adipose tissue and is a multifunctional hormone that regulates body weight homeostasis, neuroendocrine function, fertility, immune function, and angiogenesis (1) (2) (3) (4) . The biological actions of leptin on target tissues are carried out through interaction with its specific receptors, Ob-R. The leptin receptor (Ob-R) is a member of the gp130 family of cytokine receptors (5) which occurs in several receptor variants (Ob-Ra through Ob-Rf) that are generated by alternative splicing of the db leptin receptor gene. These isoforms share the same extracellular domain but differ in the length of the transmembrane/cytoplasmic (6, 7) . The long Ob-Rb subtype (Ob-R L ) appears as the functional, signal-transducing isoform, responsible for the action of leptin (8) . The long isoform, Ob-Rb, can activate the signal transducers and activators of transcription (STAT) pathways, whereas both Ob-Rb and the short isoform (Ob-Ra) can transduce signals through IRS (insulin receptor substrates) and through mitogen-activated protein kinase (MAP kinase) dependent pathways (for review see (9) ). Although, it is currently though that leptin action is largely mediated by central nervous systems, the expression of Ob-R L in peripheral tissues indicate that they are direct targets of leptin. There is now an emerging role of leptin as a growth factor for several cell types (10-12).
In the gut, leptin has been reported to stimulate the proliferation of gastric and intestinal epithelial cells through activation of the MAP kinase dependent pathways (13) (14) .
Besides this leptin growth effect, we have previously demonstrated that leptin can enhance the activity of the brush border Pept-1 transporter (15) and the uptake of butyrate via the monocarboxylate carrier MCT-1 in the human intestinal Caco-2 cells (16) .
Butyrate is a short-chain fatty acid (SCFA) that is produced in the colonic lumen by bacterial fermentation of carbohydrate and dietary fibres (17) . In the proximal large bowel, butyrate represents the preferred respiratory fuels in the intestine through β-oxidation. Apart from the function of butyrate as a dominant energy source for colonocytes, its also inhibits cellular proliferation and induces apoptosis by regulating the key proteins controlling the cell cycle (18) . In particular, NaB was shown to downregulate 25 genes including cyclin D1, a key regulator of G1/S phase and the proliferating cell nuclear antigen PCNA in colonic epithelial cells arguing for its pro-apoptotic property (19) .
In this study we investigate whether leptin could affect sodium butyrate-induced apoptosis in a human colon cancer cell line HT29 cells and examine the intracellular mechanisms involved. We demonstrated, for the first time, that leptin promotes intestinal epithelial HT29 cell survival upon butyrate challenge by counteracting the apoptotic programs initiated by this short chain fatty acid, probably through activation of NF-κB pathways.
; extracted from HT29 cells, using Trizol® according to the manufacturer's instructions. RNA T was reverse-transcribed into cDNA then amplified with Ob-Rb primers. The primers of 5'-GCCAACAACTGTGGTCTCTC-3' and 5'-AGAGAAGCACTTGGTGACTG -3' for Ob-Rb were designed on the basis of the previously published cDNA sequence for human Ob-Rb leptin receptor (GeneBank, accession number : CAA73211) which define an amplicon of 248 bp.
PCR was performed under the thermocycling conditions as follows : 1-minute denaturation at 94°C, 1-minute annealing at 57°C and 1-minute extension at 72°C for 30 cycles. The last amplification was followed by final ten-minute elongation step at 72°C. PCR products were analyzed by electrophoresis in 2% agarose gel in the presence of ethidium bromide.
Immunocytochemistry. HT29 cells were grown on glass coverslips in DMEM supplemented with 10% of fetal bovine serum for 48 hrs. Cells were fixed at room temperature for 15 min with 4% paraformaldehyde solution, then rinsed tree times with PBS. Non specific sites were blocked with 5% non-immune horse serum in PBS for 30 min. Coverslips were incubated overnight with a goat polyclonal anti-Ob-R (dilution 1:20); in humid atmosphere. After three washes for 5 min, they were labeled with a donkey anti-goat IgG conjugated to FITC cells/25cm 2 ), and let to raise exponential growth. To ensure that cells progress through the cell cycle in synchronous manner, cells were maintained in serum-free media from hours. Cells were treated with vehicle or leptin (1nM) for 24 hours. For flow cytometry analysis, cells were trypsinized, washed twice with PBS, and fixed in 80% ethanol for at least 18 hours at -20°C. Fixed cells were washed twice with PBS, and stained with mouse monoclonal FITC-conjugated cyclin D1 antibody (0.5 ng/mL) and/or with a staining solution containing RNAse A (0.2 mg/mL) and propidium iodide (10µg/mL) for 30 min at 37°C. The cell cycle was analyzed using a laser flow cytometer (Beckman Coulter). Data were acquired on a Coulter flow cytometer using Expo32 software. Ten thousand cells were acquired for analysis of HT29 cell population gated as double staining with anti-cyclinD1-FITC and propidium iodide.
Quantification of phosphorylated ERK1/2 proteins. Fast activated cell-based ELISA (Active Motif Europe, Brussels, Belgium) was used to determine ERK phosphorylation relative to the total ERK protein found in cells following the manufacturer's instructions. Briefly, HT29 cells were seeded on the 96-well plates, then serum starved for 24 hours. Then the cells were treated with leptin (1nM), NaB (5mM) either alone or in combination for various timeperiods. Afterwards, the cells were fixed, one part of wells were used for determination of phospho-ERK using a specific antibody, while the other wells were used for determination of total-ERK with another antibody, followed by incubation with HRP-conjugated antibodies and developing reagent. A sensitive colorimetric readout was quantified by spectrophotometry Confocal microscopy analysis of NF-kappa B activation. In order to determine whether the activation of transcription factor NF-κB occurred after addition of leptin, nuclear translocation of NF-κB was examined by confocal microscopy. Cells were cultured into labtek, and treated with or without 1 nM leptin for various times (0, 5, 15, 30 min, and 1, 3, 6, 9 and 24 hr). The cells were fixed as described above and were labeled with a rabbit polyclonal anti-NF-κB p65 (dilution : 1:100) followed by a FITC-conjugated anti-rabbit immunoglobulin G at dilution 1:200, then cells were stained by propidium iodide (10µg/ml).
Cells were examined under a laser scanning confocal microscope (Zeiss, LSM 510). Colocalization of the antibody to NF-κB p65 and the intercalating agent propidium iodide was DNA fragmentation. Apoptosis was evaluated by examining the characteristic pattern of DNA laddering To assay DNA fragmentation was assayed,. Briefly, after 48 hours of treatment with 1nM leptin or 5 mM NaB alone or both compounds, HT29 cells were harvested and washed in PBS. Then, a lysis buffer containing 0.6% of SDS, 10mM EDTA, and proteinase K (1 mg/mL) were added to the cells and incubated at 37°C overnight. Afterwards, NaCl was added to a concentration of 1M, mixed by inversion and centrifuged at 9000 rpm for 20min at 4°C. Supernatants were transferred and cold ethanol was added, mixed by inversion and the mixtures were left at -80°C for 1 hr, and centrifuged at 18000 rpm for 2 hrs at 4°C. DNA pellet was air dried and resuspended in 25 µL of 10 mM Tris-Hcl/ 1 mM EDTA pH 7.4.
RNAse A was added to the suspension, incubated at 37°C for 1hr and electrophoresed in 2% agarose gel containing 0.5 mg/mL ethidium bromide.
Statistics Analysis.
The results are expressed as means ± SD. They were compared by one-way analysis of variance (ANOVA), followed by a Tukey-Kramer multiple comparisons test if significant results were obtained. Values were considered statistically significant when p was less than ; RESULTS HT 29 cells express leptin receptor which mediates proliferation. By confocal microscopy (Fig1A&B), leptin-receptor immunoreactivity was detected in HT-29 cells (Fig 1A) and was mainly localized at the periphery of the cell as shown by the double fluorescent labeling with actin labeled with Phalloidin-TRITC (Fig 1B) . The immunostaining was specific since leptinreceptor immunoreactivity was no longer observed in the presence of the immunogen peptide Indeed, leptin induced a dose-dependent HT29 cell proliferation with an EC 50 value of 0.35 ± 0.02 nM (Fig 1C) . In addition, HT29 cell viability was measured after 48 hoursexposure to leptin (1 nM) or sodium butyrate (5mM) or both combined compounds (Fig 1D) .
Leptin treatment significantly increased by 1.5 fold HT29 cell proliferation (P<0.01 vs control) whereas treatment of the cells with sodium butyrate (5 mM) reduced it. In the presence of sodium butyrate, HT29 cell growth was still maintained and significantly increased by 1.6 fold upon leptin challenge (P<0.001 vs NaB). These data show that leptin acts as potent mitogen on HT29 cells growth and inhibits sodium butyrate-anti-proliferative effects.
Flow cytometric data of cell cycle analysis of serum-free control cells (Fig 2A, left panel) indicated that 92 ± 1.3% of HT29 cells are in G 0 /G 1 phase, 3.9 ± 0.5% in S phase and 2.8 ± 0.6% in G 2 /M phase. When serum-free HT29 cells were treated with 1 nM leptin for 24 hours, only 70.6 ± 1.6% of HT29 cells were found in G 0 /G 1 phase, 8.2 ± 0.2% in S phase, and 21.1 ± 0.4 % in G 2 /M phase (Fig 2A, right panel) . These data indicate that leptin is a potent mitogenic factor for HT29 cells.
These results are consistent with dot plots of cyclin D1-FITC flow of cytometry data.
As shown in Fig 2B, NaB (5 mM) alone had no significant effect on ERK phosphorylation but significantly reduced leptin-induced ERK phosphorylation (P<0.05 vs leptin alone) (Fig 3A) .
Because leptin promotes HT29 cell survival upon butyrate challenge, we investigated whether NF-κB could be involved in this effect. Leptin (1nM) induced a significant 4-fold increase in NF-κB DNA binding activity (P<0.001 vs control ) in agreement with our data in Figure 4 .
On the other hand, NaB (5 mM) alone had no effect on NF-κB DNA binding activity and did not affect leptin-induced NF-κB DNA binding activity (Fig 3B) .
Leptin induces nuclear translocation and transcriptional activity of NF-κB in HT29 cells.
Immunoblotting analysis of whole, cytoplasmic and nuclear extracts showed an increase of transcription factor NF-κB p65 immunoreactive protein in the nuclear extracts from leptintreated cells compared to control cells (Fig 4A) . In addition, in cytoplasmic extracts from leptin-treated cells, one additional immunoreactive IκB-α protein was detected compared to control (Fig 4A) suggesting that IκB-α is ongoing to degradation process. This nuclear translocation of NF-κB was confirmed by confocal microscopy studies using the co- The in vivo transcriptional activity of NF-κB was measured by the luciferase activity in HT29 cells transiently transfected with the (kappaB) 3 IFN-luciferase plasmid. Luciferase activity was 1.5 fold increase in leptin-stimulated cells as compared to control (Fig 4D) .
Leptin-induced transcriptional NF-κB p65 level is similar to that obtained with serum stimulation. Therefore, leptin activates the transcription factor NF-κB via leptin receptor in HT29 cells.
Leptin counteracts butyrate-induced apoptosis in HT-29 cells. Morphological aspects of
propidium iodide-stained HT29 cells were illustrated in Fig 5. Serum-starved HT29 cells appeared as a monolayer (Fig 5A) whereas leptin-treated HT29 cells showed some cell superposition probably due to their proliferation (Fig 5B) . Treatment of the cells with sodium butyrate (5 mM) reduced HT29 cell proliferation and induced morphological changes of the nuclei characterized by chromatin condensation (Fig 5C) . Flow cytometric analysis showed that sodium butyrate caused cell cycle arrest by blocking the cells in G 0 /G 1 phase of the cell cycle (Fig 5G) . Interestingly, treatment of HT29 cells with 1nM of leptin prevented sodium butyrate-induced morphological nucleus changes (Fig 5D) and suppressed butyrate-induced cell cycle arrest in the HT29 cells (Fig 5H) .
In addition, leptin prevented the butyrate induction of DNA laddering (Fig 6, lane 4) whereas leptin alone had no effect on genomic DNA (Fig 6, lane 3) . This anti-apoptotic effect of leptin was also associated with HT-29 cell proliferation observed 24 hours (data not shown) and even 48 hours (Fig 1D) after butyrate exposure. Moreover butyrate-treated cells exhibited an internucleosomal degradation of genomic DNA resulting in DNA laddering (Fig 6, lane 2) in agreement with the well-known pro-apoptotic property of sodium butyrate (23, 24) . 
DISCUSSION
In this report, we demonstrate that human colonic HT-29 cells expressing leptin-receptor can sense and respond to physiological concentration of leptin by increasing their proliferation. In addition, we demonstrate that leptin promotes HT29 cell survival from butyrate apoptosis.
The leptin stimulation of HT29 cell proliferation confirms earlier results suggesting that leptin is a growth factor for colonic epithelial cells (13) . These data are also closed to the in vivo results, demonstrating that leptin stimulated epithelial cell proliferation in the colon mucosa (13, 25) and those reporting an enhanced DNA content in the small intestine after chronic treatment with leptin (25) . In this study, we clearly demonstrate that the leptin induction of cell growth is associated with an increase of HT29 cell population in S and G 2 /M phase of the cell cycle. Entry into the cell cycle requires fine coordination of events from the membrane to the nucleus. Mitotic cellular division requires the cell to leave the resting state (G 0 ) and proceed through phases of DNA synthesis (S) and mitosis (M). Two gap phase G 1 and G 2 lie before and after S phase, are restriction checkpoints where the activities of cyclins promote the passages through these checkpoint. Among these cyclins, cyclin D1 is a rate-limiting for cell cycle progression (26) . We showed that cyclin D1 immunoreactivity was enhanced in (30) and (31)). In most cell types, NF-κB is sequestered in the cytoplasm in an inactive complex with IκB α or IκB β . Diverse signals induce the phosphorylation and degradation of IκB resulting in the nuclear translocation of NF-κB and thereby enhancing DNA sequence-specific gene transcription (32, 33) .
We demonstrated that leptin induces an increase in NF-κBp65 immunoreactive protein in the nucleus and the appearance of an additional IκB-α immunoreactive protein in cytosol. This transformed cells (35) (36) (37) showing that NF-κB plays a critical role in cell cycle regulation through modulation of cyclin D1 expression. Taken together, we conclude that leptin induces HT29 cell growth through activation of NF-κB which in turns increases expression of cyclin D1. Whether leptin directly affect the expression of cyclin D1 in our conditions remained to be further elucidated.
In this study, we also demonstrated that leptin prevents HT29 cells from sodium butyrate-induced apoptosis. This finding can be put forward our previous report showing that leptin enhances butyrate uptake in human intestinal Caco-2 cells through the proton-linked monocarboxylate transporter MCT-1 (16) . The SCFA, sodium butyrate is a metabolic product of microbial fermentation of carbohydrates and dietary fibres in the large bowel. Butyrate has considerable physiologic relevance to the integrity and function of the colonic epithelium and may be an important factor in the pathogenesis of diseases of the colonic epithelium (38, 39) .
Butyrate is well known to inhibit growth and stimulate the differentiation of normal and carcinoma colonic cells both in vivo and in vitro leading to apoptosis (40, 41) . Consistent with previous studies, we showed that sodium butyrate inhibits cell proliferation and induces apoptosis in colon cancer HT29 cells. Interestingly, we evidence an anti-apoptotic effect of leptin which was still associated with its ability to stimulate HT-29 cell proliferation. The precise mechanisms by which leptin promotes cell survival upon butyrate challenge remain unclear. However, the reduced phosphorylation of ERK-1/2 proteins, the unaltered activation NF-κB and the ability of butyrate-treated cells to still proliferate in response to leptin, strongly suggest that NF-κB may be the critical mediator of this effect. We conclude that However, we cannot formerly exclude the involvement of ERK pathways in this antiapoptotic effect. On the other hand, leptin has been shown to promote apoptosis in human bone marrow stromal cells through activation of ERK pathways (42) and in adipose tissue (43) . We have no clear explanation for these cell types discrepancies but it might be dependent on the cell signaling being targeted. 
